“It is said that we are experiencing a new ‘Renaissance of Biology’ enabled by technological innovation fueling vigorous research and resulting in ground-breaking discoveries in the diagnosis, treatment, and monitoring of disease. Genomic Health has had – and will continue to have – a crucial role in this ‘Renaissance’ by being a pioneer and world leader in developing best-in-class genomic-based diagnostic tests that deliver critical information to physicians to better inform optimal treatment of a patient’s cancer care. I am privileged to be part of a company that has made it a mission to improve the lives of cancer patients while simultaneously lowering healthcare costs and improving the overall standard of care. As Genomic Health continues to be industry-leading in its development and commercialization of high-quality, clinically-actionable diagnostics, we will remain steadfast in our resolve to support the patient and medical community throughout the cancer patient's journey.”

“It is said that we are experiencing a new ‘Renaissance of Biology’ enabled by technological innovation fueling vigorous research and resulting in ground-breaking discoveries in the diagnosis, treatment, and monitoring of disease. Genomic Health has had – and will continue to have – a crucial role in this ‘Renaissance’ by being a pioneer and world leader in developing best-in-class genomic-based diagnostic tests that deliver critical information to physicians to better inform optimal treatment of a patient’s cancer care. I am privileged to be part of a company that has made it a mission to improve the lives of cancer patients while simultaneously lowering healthcare costs and improving the overall standard of care. As Genomic Health continues to be industry-leading in its development and commercialization of high-quality, clinically-actionable diagnostics, we will remain steadfast in our resolve to support the patient and medical community throughout the cancer patient's journey.”